Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ASTHNASDAQ:FLYWNASDAQ:GDRXNYSE:OOMA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTHAstrana Health$25.10+3.0%$29.69$23.12▼$63.20$1.41B1291,612 shs213,219 shsFLYWFlywire$10.80+4.4%$9.84$8.20▼$23.40$1.31B1.221.79 million shs2.16 million shsGDRXGoodRx$3.91+2.6%$4.30$3.68▼$9.26$1.40B1.241.38 million shs1.16 million shsOOMAOoma$13.71+1.4%$12.73$7.83▼$17.00$377.86M1.21122,147 shs162,945 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTHAstrana Health-0.93%-0.37%-21.73%-3.94%-38.34%FLYWFlywire-2.27%-6.26%+11.18%-9.30%-41.28%GDRXGoodRx+0.53%-0.26%-18.24%-23.49%-47.23%OOMAOoma+0.30%+0.37%+10.23%-6.37%+57.80%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTHAstrana Health3.6424 of 5 stars3.34.00.00.02.10.83.1FLYWFlywire4.0189 of 5 stars4.13.00.00.03.42.51.9GDRXGoodRx3.1025 of 5 stars3.32.00.00.03.51.71.9OOMAOoma2.3128 of 5 stars3.43.00.00.01.91.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTHAstrana Health 2.67Moderate Buy$53.29112.29% UpsideFLYWFlywire 2.21Hold$15.4242.75% UpsideGDRXGoodRx 2.64Moderate Buy$6.5567.40% UpsideOOMAOoma 2.80Moderate Buy$17.6328.56% UpsideCurrent Analyst Ratings BreakdownLatest OOMA, ASTH, FLYW, and GDRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025GDRXGoodRxUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.255/9/2025GDRXGoodRxThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$6.00 ➝ $5.005/8/2025FLYWFlywireThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$10.00 ➝ $12.005/7/2025FLYWFlywireRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$20.00 ➝ $17.005/7/2025FLYWFlywireWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$16.00 ➝ $13.005/2/2025FLYWFlywireB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$29.00 ➝ $17.004/29/2025GDRXGoodRxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$8.00 ➝ $7.004/23/2025FLYWFlywireWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Peer Perform4/14/2025FLYWFlywireJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$16.00 ➝ $9.004/10/2025GDRXGoodRxTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$6.50 ➝ $5.504/2/2025FLYWFlywireThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $11.00(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTHAstrana Health$2.25B0.63$0.96 per share26.15$10.58 per share2.37FLYWFlywire$511.49M2.57$0.04 per share255.58$6.41 per share1.68GDRXGoodRx$797.41M1.75$0.33 per share11.77$1.93 per share2.03OOMAOoma$256.85M1.47$0.40 per share34.23$3.03 per share4.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTHAstrana Health$60.72M$0.7219.3117.801.373.63%9.37%5.32%8/6/2025 (Estimated)FLYWFlywire-$8.57M$0.0472.0043.201.414.23%2.49%1.86%8/5/2025 (Estimated)GDRXGoodRx-$8.87M$0.08N/A21.722.46-2.05%5.35%2.51%8/14/2025 (Estimated)OOMAOoma-$830K-$0.26N/A1,371.00N/A-3.83%-2.51%-1.32%N/ALatest OOMA, ASTH, FLYW, and GDRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025ASTHAstrana Health$0.23$0.14-$0.09$0.14$628.11 million$620.39 million5/7/2025Q1 2025GDRXGoodRx$0.04$0.09+$0.05$0.03$202.25 million$202.97 million5/6/2025Q1 2025FLYWFlywire$0.01$0.03+$0.02-$0.03$124.18 million$128.70 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTHAstrana HealthN/AN/AN/AN/AN/AFLYWFlywireN/AN/AN/AN/AN/AGDRXGoodRxN/AN/AN/AN/AN/AOOMAOomaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTHAstrana Health0.601.911.91FLYWFlywireN/A2.332.33GDRXGoodRx0.705.485.48OOMAOoma0.041.080.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTHAstrana Health52.77%FLYWFlywire95.90%GDRXGoodRx63.77%OOMAOoma80.42%Insider OwnershipCompanyInsider OwnershipASTHAstrana Health8.46%FLYWFlywire3.90%GDRXGoodRx4.53%OOMAOoma9.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTHAstrana Health1,90056.06 million51.49 millionOptionableFLYWFlywire660121.56 million119.57 millionOptionableGDRXGoodRx950357.17 million365.25 millionOptionableOOMAOoma38027.56 million24.37 millionOptionableOOMA, ASTH, FLYW, and GDRX HeadlinesRecent News About These CompaniesOoma reaffirms $267M–$270M FY2026 revenue target as AirDial partnership momentum acceleratesMay 30 at 6:49 PM | msn.comOoma (NYSE:OOMA) Posts Earnings Results, Misses Estimates By $0.13 EPSMay 30 at 4:58 PM | marketbeat.comOoma Reports Fiscal First Quarter 2026 Financial ResultsMay 30 at 5:02 AM | morningstar.comOoma, Inc. (NYSE:OOMA) Q1 2026 Earnings Call TranscriptMay 29 at 11:55 PM | msn.comBenchmark Maintains Buy Rating on Ooma, Cites AirDial as Key Growth CatalystMay 29 at 11:55 PM | msn.comOoma Reports Steady Growth in Q1 2026 EarningsMay 29 at 12:35 AM | tipranks.comOoma, Inc. (OOMA) Q1 2026 Earnings Call TranscriptMay 28 at 11:08 PM | seekingalpha.comOoma (OOMA) Beats Q1 Earnings and Revenue EstimatesMay 28 at 6:26 PM | zacks.comZacks Industry Outlook Highlights Harmonic, Ooma and AudioCodesMay 28 at 7:12 AM | uk.finance.yahoo.com3 Communication Stocks Likely to Surpass Industry ConundrumsMay 26, 2025 | zacks.comExploring Analyst Estimates for Ooma (OOMA) Q1 Earnings, Beyond Revenue and EPSMay 26, 2025 | zacks.comD. E. Shaw & Co. Inc. Has $1.06 Million Stock Position in Ooma, Inc. (NYSE:OOMA)May 26, 2025 | marketbeat.comOoma (OOMA) Expected to Announce Quarterly Earnings on WednesdayMay 26, 2025 | americanbankingnews.com30,644 Shares in Ooma, Inc. (NYSE:OOMA) Purchased by Connective Capital Management LLCMay 23, 2025 | marketbeat.comOoma (OOMA) Projected to Post Earnings on WednesdayMay 23, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Sells 57,151 Shares of Ooma, Inc. (NYSE:OOMA)May 18, 2025 | marketbeat.comOoma, Inc. (NYSE:OOMA) Position Increased by Cubist Systematic Strategies LLCMay 17, 2025 | marketbeat.comOoma to Attend the 45th Annual William Blair Growth Stock ConferenceMay 15, 2025 | 01net.itDimensional Fund Advisors LP Has $4.01 Million Holdings in Ooma, Inc. (NYSE:OOMA)May 15, 2025 | marketbeat.comOoma, Inc. (NYSE:OOMA) Given Consensus Rating of "Moderate Buy" by BrokeragesMay 10, 2025 | marketbeat.comOoma Schedules Release of First Quarter Fiscal 2026 ResultsMay 7, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOOMA, ASTH, FLYW, and GDRX Company DescriptionsAstrana Health NASDAQ:ASTH$25.10 +0.72 (+2.95%) Closing price 04:00 PM EasternExtended Trading$24.95 -0.15 (-0.60%) As of 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.Flywire NASDAQ:FLYW$10.80 +0.46 (+4.45%) Closing price 04:00 PM EasternExtended Trading$10.75 -0.05 (-0.46%) As of 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Flywire Corporation, together with its subsidiaries, operates as a payments enablement and software company in the United States and internationally. Its payment platform and network, and vertical-specific software help clients to get paid and help their customers to pay. The company's platform facilitates payment flows across multiple currencies, payment types, and payment options, as well as provides direct connections to alternative payment methods, such as Alipay, Boleto, PayPal/Venmo, and Trustly. It serves education, healthcare, travel, and business to business organizations. The company was formerly known as peerTransfer Corporation and changed its name to Flywire Corporation in December 2016. Flywire Corporation was incorporated in 2009 and is headquartered in Boston, Massachusetts.GoodRx NASDAQ:GDRX$3.91 +0.10 (+2.62%) Closing price 04:00 PM EasternExtended Trading$3.92 +0.01 (+0.38%) As of 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.Ooma NYSE:OOMA$13.71 +0.19 (+1.41%) Closing price 03:59 PM EasternExtended Trading$13.98 +0.27 (+1.97%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ooma, Inc. provides communications services and related technologies for businesses and consumers in the United States and Canada. The company's products and services include Ooma Office, a cloud-based multi-user communications system for small and medium-sized businesses; Ooma Connect, which delivers fixed wireless internet connectivity; and Ooma Enterprise, a unified-communications-as-a-service (UCaaS) solution. It also provides Ooma AirDial, a plain old telephone service; PureVoice HD, a residential phone services; Ooma basic that provides unlimited personal calling within the United States; and Ooma Premier, a suite of advanced calling features on a monthly or annual subscription basis. In addition, the company offers Ooma Telo, a home communications solution designed to serve as the primary phone line in the home; Ooma Telo Air, a wireless Ooma Telo with built-in Wi-Fi and Bluetooth; and Ooma Telo LTE, which combines the Ooma Telo base station with the Ooma LTE Adapter and battery back-up. Further, it provides Ooma Mobile HD app that allows users to make and receive phone calls and access Ooma features and settings; 2600Hz provides business communication applications; Talkatone mobile app; and OnSIP, an UCaaS solutions. The company offers its products through direct sales, distributors, retailers, and resellers, as well as online and sale representatives. Ooma, Inc. was incorporated in 2003 and is headquartered in Sunnyvale, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell Ackman Takes a Swing at Amazon — Should You? Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Intel’s Turnaround May Be the Best Bet No One’s Watching Nike’s Amazon Expansion Could Signal a Turnaround in 2025 ASML Stock Might Be the Safest Chip Play at This Price Archer Aviation Stock Steadies After Short-Seller Report e.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
